Introduction: Depressive disorders are one of the greatest public health challenges worldwide, affecting up to 16% of the population over a lifetime and significantly impacting quality of life, disability, and premature mortality. Major depressive disorder (MDD) is a leading cause of disability, despite the availability of numerous treatment options. In 20–50% of patients, traditional pharmacotherapy and psychotherapy become ineffective, leading to a diagnosis of treatment-resistant depression (TRD). Objective: The objective of this study was to provide a thorough assessment of current research findings evaluating the efficacy and safety of psilocybin-assisted therapy (PAT) in patients with MDD and TRD, with particular emphasis on rapid antidepressant effects and long-term therapeutic potential. Methods: A literature review was conducted in the PubMed and Google Scholar databases. Keywords related to psilocybin, depression, treatment-resistant depression, and psychedelic-assisted therapy were used. Results: Psilocybin-assisted psychotherapy is a promising alternative for the treatment of MDD, TRD, and secondary depression. Compared to traditional antidepressants, PAT is characterized by a faster onset of action, symptom reduction often occurs as early as the first week after starting therapy, and the achieved results may persist long-term for up to 6–12 months. In addition, many patients showed improvement in anhedonia, anxiety, and overall psychosocial functioning. Conclusions: Psilocybin represents a promising therapeutic alternative for patients with severe depression and TRD, offering rapid and lasting antidepressant effects. Its use could significantly change the approach to treating depression, particularly in cases resistant to standard therapies.
15 August 2026 in International Journal of Innovative Technologies in Social Science
Melanoma is a highly aggressive skin cancer with a steadily increasing annual incidence. Although it accounts for only 1% of diagnosed skin cancers, it has the highest mortality rate among them. Therefore, it is essential to continuously develop treatment methods and improve long-term outcomes. In recent years, a breakthrough has been the introduction of adjuvant therapy following surgical treatment, which has become the standard of treatment. This has led to an increase in recurrence-free survival and overall survival in high-risk patients. Immunotherapy with anti-CTLA-4 and anti-PD-1 antibodies, as well as targeted therapy for patients with BRAF mutations, have become part of the standard of care. These are recommended for patients with stage IIB–IV melanoma at high risk of recurrence to eliminate micrometastases. Various treatment regimens targeting different patient subgroups are still being investigated to optimize outcomes and minimize adverse effects. This paper reviews and discusses current adjuvant treatment strategies for melanoma. In addition, it highlights the emerging role and future potential of these therapies in the neoadjuvant setting.
31 August 2026 in International Journal of Innovative Technologies in Social Science
Recurrent upper respiratory tract infections (URTIs) represent a significant clinical challenge in otolaryngology, with growing evidence suggesting that intestinal microbiota may play an important role in their pathogenesis. The gut-lung axis describes bidirectional immunological, metabolic, and microbial communication between the gastrointestinal and respiratory systems. Disturbances in gut microbiota composition, known as dysbiosis, can impair mucosal immunity through altered IgA production, reduced regulatory T‑cell activity, and decreased levels of immunomodulatory metabolites such as short‑chain fatty acids. These changes may increase susceptibility to infections of the pharynx, sinuses, and middle ear, contributing to their chronic and recurrent course. Frequent antibiotic use, common in ENT practice, may further exacerbate dysbiosis, creating a potential vicious cycle of recurrent infections. Emerging therapeutic strategies - such as probiotics, prebiotics, dietary interventions, and personalized microbiome‑based approaches - offer promising but yet insufficiently validated avenues for supporting standard treatment. Further prospective clinical studies are required to better define the role of the gut-lung axis in the development and management of recurrent ENT infections and to assess the effectiveness of microbiome‑modulating therapies.
31 August 2026 in International Journal of Innovative Technologies in Social Science
Background: Contemporary intensive care units (ICUs) generate vast amounts of real-time data, leading to staff cognitive overload and the phenomenon of alarm fatigue. Traditional prognostic scoring systems (APACHE II, SOFA) are inherently static and fail to account for dynamic clinical trends. Artificial intelligence (AI) algorithms, including machine learning (ML) and deep learning (DL), offer novel capabilities for continuous monitoring and early prediction of life-threatening conditions. Objective: To analyze the clinical potential and implementation challenges associated with the deployment of AI algorithms in intensive care settings. Methods: A comprehensive literature review was conducted across the PubMed, Embase, and IEEE Xplore databases for the years 2018–2026, focusing on studies utilizing multicenter databases (such as MIMIC-IV and eICU). Results: AI algorithms demonstrate high discriminative performance (AUROC 0.79–0.96) in the early detection of sepsis, prediction of hemodynamic instability with a 5-to-15-minute lead time, and dynamic mortality risk estimation. In the context of mechanical ventilation, deep learning models (specifically convolutional neural networks, CNNs) enable automated detection of patient-ventilator asynchrony with an accuracy exceeding 90%, as well as precise forecasting of extubation success. Conclusions: Artificial intelligence holds immense potential for optimizing ICU patient care. However, primary implementation barriers persist, including the lack of model interpretability (the "black box" problem), domain shift, and ethico-psychological dilemmas, such as clinician moral distress and the risk of care dehumanization. AI systems should function strictly as clinical decision support tools under physician supervision.
7 September 2026 in International Journal of Innovative Technologies in Social Science
Obesity represents one of the most significant public health challenges worldwide, serving as a key risk factor for numerous chronic diseases, including type 2 diabetes and cardiovascular diseases. The aim of this article was to present modern approaches to obesity management, with particular emphasis on the role of health behaviors, diet therapy, dietary catering services, and semaglutide-based pharmacotherapy. This paper reviews issues related to the concept of health and health behaviors, principles of proper nutrition, and selected dietary models used in obesity treatment. Special attention was paid to dietary catering as a modern tool supporting the implementation of nutritional recommendations, as well as pharmacotherapy utilizing GLP-1 receptor agonists. The conducted analysis indicates that effective obesity treatment requires a comprehensive and interdisciplinary approach, combining lifestyle modification, appropriately tailored diet therapy, and pharmacological support. Modern solutions, such as personalized nutrition and the use of semaglutide-based medications, can significantly increase treatment efficacy and promote long-term weight reduction.
2 July 2026 in International Journal of Innovative Technologies in Social Science
The aim of this study is to analyze the psychogenic and clinical factors influencing the emotional state of women during pregnancy and to discuss the possibilities for the treatment and prediction of mental disorders using artificial intelligence (AI). The article presents the physiological and psychosocial determinants of emotional functioning in pregnant women, with particular emphasis on risk factors for mood disorders, such as depression and anxiety. Contemporary therapeutic approaches utilized in the perinatal period are discussed, encompassing both medical methods and non-medical forms of psychological support. Special attention is devoted to the role of modern technologies—including machine learning algorithms, mobile applications, and chatbots—in the process of early disorder detection and mental health support for pregnant women. Furthermore, the significance of diagnostic tools, such as ultrasonography (USG) and cardiotocography (CTG), in monitoring fetal well-being is addressed, alongside their potential integration with AI-based systems. The literature review indicates that AI can serve as a significant supplement to traditional medical care, contributing to improved diagnostic quality, enhanced predictive capabilities and increased accessibility of support for pregnant women.